Synthesis 2022; 54(09): 2267-2281
DOI: 10.1055/s-0040-1719873
paper

Synthesis of Novel Pyrazine-Substituted 1H-Pyrrole-2-carboxamides and Related Tethered Heterocycles

Rachel L. Howells
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Scott G. Lamont
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Thomas M. McGuire
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Samantha Hughes
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Rachel Borrows
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Gary Fairley
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Lyman J. L. Feron
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Ryan D. R. Greenwood
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Eva Lenz
a   AstraZeneca R & D, Darwin Building (310), Cambridge Science Park, Milton Road, Cambridge, CB4 0WG, UK
,
Emma Grant
b   Formerly of AstraZeneca R & D, Cambridge, UK
,
Iain Simpson
b   Formerly of AstraZeneca R & D, Cambridge, UK
› Author Affiliations


Abstract

As part of a drug discovery program, 4-pyrazin-2-yl-1H-pyrrole-2-carboxamides were accessed along with a number of bicyclic analogues. Routes to these compounds were largely absent from the scientific literature. The synthesis of a 4-(pyrazin-2-yl)-1H-pyrrole-2-carboxamide and several fused bicyclic analogues all using standard procedures (SNAr, borylation, C–C cross couplings, hydrolysis, amide bond formation, cyclisation, halogenation, and alkylation) from readily available starting materials is reported. The synthetic sequences range from 4–12 steps per final compound, with yields of isolated intermediates ranging from 20 to ∼100%.

Supporting Information



Publication History

Received: 01 October 2021

Accepted after revision: 29 November 2021

Article published online:
26 January 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

    • 1a Vitaku E, Smith DT, Njardarson JT. J. Med. Chem. 2014;  57:  10257
    • 1b Taylor RD, MacCoss M, Lawson AD. G. J. Med. Chem. 2014; 57: 5845
    • 1c Baumann M, Baxendale IR, Ley SV, Nikbin N. Beilstein J. Org. Chem. 2011; 7: 442
    • 1d Baumann M, Baxendale IR. Beilstein J. Org. Chem. 2013; 9: 2265
  • 2 Gerpacher M, Furet P, Vangrevelinghe E, Pissot Soldermann C, Gaul C, Holzer P. PCT Int. Appl WO 2008148867, 2008
    • 3a Norio M, Kinji Y, Suzuki A. Tetrahedron Lett. 1979; 20: 437
    • 3b Norio M, Suzuki A. J. Chem. Soc., Chem. Commun. 1979; 866
    • 3c Norio M, Suzuki A. Chem. Rev. 1995; 95: 2457
    • 3d Suzuki A. Pure Appl. Chem. 1991; 63: 419
    • 3e Suzuki A. J. Organomet. Chem. 1999; 576: 147
    • 4a Hasan I, Marinelli ER, Lin L.-CC, Fowler FW, Levy AB. J. Org. Chem. 1981; 46: 157
    • 4b Ravinder K, Reddy V, Mahesh KC, Narasimhulu M, Venkateswarlu Y. Synth. Commun. 2007; 37: 281
    • 5a Harijan RK, Hoff O, Ducati RG, Firestone RS, Hirsch BM, Evans GB, Schramm VL, Tyler PC. J. Med. Chem. 2019;  62: 3286
    • 5b Rodriguez ME, Mareska DA, Hans JJ, Harvey DM, Groneberg RD, O’Sullivan M. PCT Int. Appl WO 2010080864, 2010
    • 5c Morris P, Montgomery J, Babu Y. U.S. Pat. Appl. Publ US20010053784, 2001
    • 5d Maruyama T, Kozai S, Manabe T, Yazima Y, Satoh Y, Takaku H. Nucleosides Nucleotides 1999;  18:  2443
    • 6a Wu X, Arndt T, Feuerstein T, Biesinger R, Essers M, Schneider M, Hochguertel M, Van Veldhuizen J, Sucholeiki I, Deng H, Kroth H, Bluhm H, Richter F, Steeneck C, Gege C, Gallagher B, Nolte B, Taveras AG. U.S. Pat. Appl. Publ 20070155738, 2007
    • 6b Kamath VP, Juarez-Brambila JJ, Morris CB, Winslow CD, Morris PE. Org. Process Res. Dev. 2009; 13: 928
    • 6c Brakta M, Daves GD. J. Chem. Soc., Perkin Trans. 1 1992; 1883
    • 6d Furneaux RH, Tyler PC. J. Org. Chem. 1999; 64: 8411
    • 7a Fidanze SD, Liu D, Mantei RA, Hasvold LA, Pratt JK, Sheppard GS, Wang L, Holms JH, Dai Y, Aguirre A, Bogdan A, Dietrich JD, Marjanovic J, Park CH, Hutchins CW, Lin X, Bui MH, Huang X, Wilcox D, Li L, Wang R, Kovar P, Magoc TJ, Rajaraman G, Albert DH, Shen Y, Kati WM, McDaniel KF. Bioorg. Med. Chem. Lett. 2018; 28: 1804
    • 7b Wang L, Pratt J, Hasvold LA, Liu D, Dai Y, Fidanze SD, Holms JH, Mantei RA, McDaniel KF, Sheppard GS, McClellan WJ. U.S. Pat. Appl. Publ US20140275026, 2014
    • 7c Liu D, Pratt J, Wang L, Hasvold LA, Bogdan A. U.S. Pat. Appl. Publ US20140256710, 2014
    • 7d DeWitte RS, Shakhnovich EI. J. Am. Chem. Soc. 1996; 118: 1733
    • 7e Matsuda Y, Ide S, Furuno K, Itou T, Motokawa C, Chiyomaru Y. Tetrahedron 1993;  49:  9947
    • 8a Tsutsumi T, Sugiura S, Koga M, Matsumoto Y, Ishii T, Nakano A, Unoki G, Sakai Y, Takarada R, Ogawa H. U.S. Pat. Appl. Publ US7557113, 2009
    • 8b Jukic L, Svete J, Golobic A, Golic L, Stanovnik B. Heterocycles 2000;  53: 805
    • 8c Xie H, Zeng L, Zeng S, Lu X, Zhang G, Zhao X, Cheng N, Tu Z, Li Z, Xu H, Yang L, Zhang X, Huang M, Zhao J, Hu W. Eur. J. Med. Chem. 2012; 52: 205
    • 8d Tsutsumi T, Sugiura S, Koga M, Matsumoto Y, Ishii T, Nakano A, Unoki G, Sakai Y, Takarada R, Ogawa K. PCT Int. Appl WO2005019219, 2005
    • 8e Tsutsumi T, Sugiura S, Koga M, Matsumoto Y, Ishii T, Nakano A, Unoki G, Sakai Y, Takarada R, Ogawa H. PCT Int. Appl WO2005019218, 2005
    • 8f Altman E, Missbach M, Widler L, Maibaum JK. PCT Int. Appl WO9749706, 1997
    • 8g Secrist JA. III, Niwas S, Rose JD, Sudhakar Babu Y, Bugg CE, Erion MD, Guida WC, Ealick SE, Montgomery JA. J. Med. Chem. 1993;  36: 1847
  • 9 Lu H, Wang S, Li J, Zou D, Wu Y, Wu Y. Tetrahedron Lett. 2017; 58: 839
    • 10a Milstein D, Stille JK. J. Am. Chem. Soc. 1978; 100: 3636
    • 10b Milstein D, Stille JK. J. Am. Chem. Soc. 1979; 101: 4992
    • 11a Neihsal S, Lyngdoh RH. D. J. Comput. Chem. 2008; 29: 1788
    • 11b Chang H, Charmot D, Glinka T, Cope MJ, Goka E, Shao J, Cartigny D, Chen S, Buysse JM. PCT Int. Appl WO 2007056281, 2007
    • 11c Cristalli G, Franchetti P, Grifantini M, Nasini E, Vittori S. Org. Prep. Proced. Int. 1988; 20: 285
    • 11d Ducrocq C, Bisagni E, Lhoste JM, Mispelter J, Defaye J. Tetrahedron 1976; 32: 773
    • 11e Clark BA. J, El-Bakoush MM. S, Parrick J. J. Chem. Soc., Perkin Trans. 1 1974; 1531
    • 12a Ramphal JY, Buckman BO, Emayan K, Nicholas JB, Seiwert SD. PCT Int. Appl WO 2015153683, 2015
    • 12b Buckman BO, Nicholas JB, Ramphal JY, Emayan K, Seiwert SD. PCT Int. Appl. WO 2014055548, 2014
    • 12c Buckman BO, Nicholas JB, Ramphal JY, Emayan K, Seiwert SD. U.S. Pat. Appl US 20140094456, 2014
    • 12d Cheung LL. W, Yudin AK. Chem. Eur. J. 2010; 16: 4100
    • 12e Cheung LL. W, Yudin AK. Org. Lett. 2009; 11: 1281
    • 12f Clark RD, Jahangir A. Org. React. 1995; 47: 1
    • 12g Davis JM, Mack SR, Sabin VM, Davenport RJ. PCT Int. Appl. WO 2002062816, 2002
    • 12h Clark RD, Miller AB, Berger J, Repke DB, Weinhardt KK, Kowalczyk BA, Eglen RM, Bonhaus DW, Lee CH, Michel AD, Smith WL, Wong EH. F. J. Med. Chem. 1993; 36: 2645
    • 12i New JS, Christopher WL, Yevich JP, Butler R, Schlemmer RF. Jr, VanderMaelen CP, Cipollina JA. J. Med. Chem. 1989; 32: 1147
    • 12j Bisagni E, Hung NC, Lhoste JM. Tetrahedron. 1983; 39: 1777
    • 12k Bisagni E, Bourzat JD, Marquet JP, Labrid C, Delort P, Le Ridant A. Chim. Ther. 1973; 8: 559
    • 12l Bisagni E, Bourzat JD, Marquet JP. Fr. Demande FR 2174746, 1973
    • 12m Bisagni E, Bourzat JD. Fr. Demande FR 2063918, 1971
    • 12n Bisagni E, Bourzat J, Andre-Luisfert J. Tetrahedron 1970; 26: 2097
    • 13a Schneider M, Newton G, Chapman K, Jarvis A, Aqil R, Reisinger T, Bayford M, Chapman N, Martin N. PCT Int. Appl WO 2020115481, 2020
    • 13b Anderson DR, Volkmann RA, Mennite FS, Fanger C. PCT Int. Appl WO 2017100591, 2017
    • 13c Nara H, Daini M, Kaieda A, Kamei T, Imaeda T, Kikuchi F. PCT Int. Appl WO 2013180265, 2013
    • 14a Ujjinamatada RK, Pandit C. PCT Int. Appl WO 2016185342, 2016
    • 14b Allmann TC, Moldovan R, Jones PG, Lindel T. Chem. Eur. J. 2016; 22: 111
    • 14c Babaoglu K, Brizgys G, Cha J, Chen X, Guo H, Halcomb RL, Han X, Huang R, Liu H, McFadden R. PCT Int. Appl WO 2013159064, 2013
    • 14d Jorgensen WL, Ruiz-Caro J, Hamilton AD. PCT Int. Appl WO 2007038387, 2007
    • 14e Romero RS, Franco F, Castaneda AC, Muchowski JM. U.S. Patent US 5041442, 1991
    • 15a Hermann J, Petersen AC, Wanner J, Yi L. U.S. Pat. Appl. Publ US 20130345226, 2013
    • 15b Dorsch D, Buchstaller HP, Moinet G, Wegener A. PCT Int. Appl WO 2013143663, 2013
    • 15c Billinton A, Clayton NM, Stevens DA. PCT Int. Appl WO 2008116816, 2008
    • 15d Jones P, Kinzel O, Llauger Bufi L, Muraglia E, Pescatore G, Torrisi C. PCT Int. Appl WO 2007138355, 2007
    • 15e Eatherton AJ, Giblin GM. P, Mitchell WL. PCT Int. Appl WO 2007088168, 2007
  • 16 Zhou B, Luo C, Li Z, Yang Y, Chen S, Ding H, Jiang H, Qiao G, Wang X, Xiao S. Faming Zhuanli Shenqing Gongkai Shuomingshu CN 110041333, 2019
  • 17 Zhou B, Luo C, Li Z, Yang Y, Chen S, Ding H, Jiang H, Qiao G, Wang X, Xiao S. PCT Int. Appl WO2019141131, 2019
  • 18 Abushanab E, Lee DY, Goodman L. J. Org. Chem. 1975; 40: 3376
    • 19a Tanaka A, Sugimoto N, Muramoto R, Nokura Y. PCT Int. Appl WO2019131587, 2019
    • 19b Kehler J, Rasmussen LK, Langgaard M, Jessing M, Vital PJ. V, Juhl K. PCT Int. Appl WO2018078042, 2018
    • 19c Kehler J, Rasmussen LK, Langgaard M, Jessing M, Vital PJ. V, Juhl K. PCT Int. Appl WO 2016174188, 2016
    • 19d Cook BN, Kuzmich D. PCT Int. Appl WO 2011056440, 2011
    • 19e Kubo K, Kuroita T, Imaeda Y, Kawamura M. PCT Int. Appl WO 2004048363, 2004
    • 20a Marx MA, Grillot A, Louer CT, Beaver KA, Bartlett PA. J. Am. Chem. Soc. 1997; 119: 6153
    • 20b Anderson DR, Meyers MJ, Vernier WF, Mahoney MW, Kurumbail RG, Caspers N, Poda GI, Schindler JF, Reitz DB, Mourey RJ. J. Med. Chem. 2007; 50: 2647
    • 20c Pettus LH, Andrews KL, Booker SK, Chen J, Cee VJ, Chavez FJr, Chen Y, Eastwood H, Guerrero N, Herberich B, Hickman D, Lanman BA, Laszlo JIII, Lee MR, Russell Lipford J, Mattson B, Mohr C, Nguyen Y, Norman MH, Powers D, Reed AB, Rex K, Sastri C, Tamayo N, Wang P, Winston JT, Wu B, Wu T, Wurz RP, Xu Y, Zhou Y, Tasker AS, Wang H. J. Med. Chem. 2016; 59: 6407
    • 20d Wuonola MA, Smallheer JM. Tetrahedron Lett. 1992; 33: 5697
    • 20e Bock MG, Gaul C, Gummagi VR, Moebitz H, Sengupta S. PCT Int. Appl WO2012035078, 2012
  • 21 Greenwood R, Yeung K. Tetrahedron Lett. 2016; 57: 5812
    • 22a Commercial product, CAS 720693-19-6.
    • 22b Sengmany S, Lebre J, Le Gall E, Leonel E. Tetrahedron 2015; 71: 4859
    • 23a Commercial product, CAS 942070-38-4.
    • 23b Kallepalli VA. J. Org. Chem. 2009; 74: 9199
    • 24a Commercial product, CAS 294659-30-6.
    • 24b Bernard H, Bülow G, Lange UE. W, Mack H, Pfeiffer T, Schäfer B, Seitz W, Zierke T. Synthesis 2004; 2367
    • 25a Commercial product, CAS 54879-88-8.
    • 25b Bristow NW. J. Chem. Soc. 1954; 616
    • 25c Kermak WO, Perkin WH, Robinson R. J. Chem. Soc., Trans. 1922; 121: 1872
    • 26a Commercial product, CAS 160590-40-9
    • 26b Lit. mp 102 C: Evans GB, Furneaux RH, Hutchison TL, Kezar HS, Morris Philip EJr, Schramm Vern L, Tyler Peter C. J. Org. Chem. 2001; 66: 5723
    • 27a Commercial product, CAS 890656-26-5.
    • 27b Rochais C. Bioorg. Med. Chem. 2006; 14: 8162
    • 28a Commercial product, CAS 252932-49-3.
    • 28b See ref. 6d.
    • 29a Commercial product CAS 93587-23-6.
    • 29b Sizova OS, Modnikova GA, Glushkov RG, Solov’eva NP, Ryabokon’ NA, Chernov VA, Okinshevich OV, Pershin GN. Pharm. Chem. J. 1984; 18: 567
    • 30a Commercial product, CAS 848841-62-3.
    • 30b Fink CA, Perez LB, Ramsey TM, Yusuff N, Versace RW, Batt DB, Sabio ML, Kim S. World Intellectual Property Organization WO2005028444 A1, 2005
    • 31a Commercial product, CAS 28383-57-5.
    • 31b Lindel T, Hochgurtel M, Assmann M, Köck M. J. Nat. Prod. 2000; 63: 1566
    • 31c Clark BR, O’Connor S, Fox D, Leroyb J, Murphy CD. Org. Biomol. Chem. 2011; 9: 6306
    • 32a Commercial product, CAS 1262630-80-7.
    • 32b Movassaghi M, Hergenrother PJ. US20150080405, 2015
    • 33a Commercial product, CAS 40262-73-5.
    • 33b Foks H, Buraczewska M, Manowska W, Sawlewicz J. Dissert. Pharm. Pharmacol. 1972; 24: 577
    • 34a Commercial product, CAS 939412-86-9.
    • 34b Mulvihill KM, Castelhano AL. US20070129547, 2007